Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

J&J's Supplement Step With Zarbees Helps Drive A Leap For Consumer Health Growth

Executive Summary

Supplement brand being marketed to compete with OTC drugs, including J&J's own brands, in cough and cold and other categories helped J&J overall consumer health sales grow 9.7% to $440m in Q3. Oral care brands showed 3.2% worldwide growth to $384m, benefiting from recent launch of chewable Listerine Ready! Tabs.

Advertisement

Related Content

Supplements More 'Mainstream' Than Alternative In Consumer Health Market
J&J’s Mesquita predicts market shift
Adding Zarbee's, J&J Gains Natural Market Footprint, Claims Credibility
J&J Consumer Health On Solid Footing With Help From Personal Care Sales
Sensitivity To Flu Helped OTC Drug Firms End 2017 With Sales Boost
J&J plots path ahead for 2018

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

PS124089

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel